(Q38910371)

28289244

7 September 2017

title

Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer (English)

1 reference

7 September 2017

David Basanta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

Alexander R A Anderson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

publication date

13 March 2017

1 reference

28289244

Cold Spring Harbor Perspectives in Medicine

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Biology, ecology and management of the invasive parthenium weed (Parthenium hysterophorus L.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Estimating dose painting effects in radiotherapy: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The mathematics of cancer: integrating quantitative models

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Integrative mathematical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolution of cooperation among tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The evolution of n-player cooperation-threshold games and ESS bifurcations

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The reactive stroma microenvironment and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Exploiting ecological principles to better understand cancer progression and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The evolution of robust development and homeostasis in artificial organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Computational analysis of the influence of the microenvironment on carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Exploiting evolution to treat drug resistance: combination therapy and the double bind

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Why Darwin would have loved evolutionary game theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Modelling aspects of cancer dynamics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Modeling invasion of metastasizing cancer cells to bone marrow utilizing ecological principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The emergence of environmental homeostasis in complex ecosystems

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Nonheritable cellular variability accelerates the evolutionary processes of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Mathematical oncology: cancer summed up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumour Cell Heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolving homeostatic tissue using genetic algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

IntOGen-mutations identifies cancer drivers across tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary determinants of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Clonal evolution in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Metabolic Heterogeneity in Human Lung Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary game theory: cells as players

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary dynamics of intratumor heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Influence of tumour micro-environment heterogeneity on therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

What can ecology teach us about cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Edge effects in game-theoretic dynamics of spatially structured tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Spatial interactions and cooperation can change the speed of evolution of complex phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Turning ecology and evolution against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Molecular signatures database (MSigDB) 3.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Osteoblasts in prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The extracellular matrix: a dynamic niche in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Environment-mediated drug resistance: a major contributor to minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer as an evolutionary and ecological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Dynamics of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Physical and Mathematical Modeling in Experimental Papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Friends or foes - bipolar effects of the tumour stroma in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Molecular signatures of natural selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Adjuvant chemotherapy--yes or no? Prognostic markers in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Hybrid models of tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Big Bang and context-driven collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Early-warning signals for critical transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Anticipating critical transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Sequencing small genomic targets with high efficiency and extreme accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Not just a theory--the utility of mathematical models in evolutionary biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Immunogenic peptide discovery in cancer genomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

A Big Bang model of human colorectal tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Perspectives on tissue interactions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cellular Mechanisms Underlying Intertumoral Heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Evolutionary Ecology of Organs: A Missing Link in Cancer Development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer: whispering sweet somethings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Modelling the consequences of interactions between tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Critical transitions in chronic disease: transferring concepts from ecology to systems medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Identification of neutral tumor evolution across cancer types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Discovery of co-occurring driver pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Abstract 4875: Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A028332

Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity.

21 January 2018

1 reference

12 December 2020

A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion

1 reference

12 December 2020

Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion

1 reference

12 December 2020

Dissecting cancer through mathematics: from the cell to the animal model

1 reference

12 December 2020

How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine

1 reference

12 December 2020

Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game

1 reference

12 December 2020

1 reference

12 December 2020

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

1 reference

12 December 2020

Intratumor heterogeneity: evolution through space and time

1 reference

12 December 2020

Cancer heterogeneity: implications for targeted therapeutics

1 reference

12 December 2020

Applying ecological and evolutionary theory to cancer: a long and winding road

1 reference

12 December 2020

Cooperation and competition in the dynamics of tissue architecture during homeostasis and tumorigenesis.

1 reference

12 December 2020

The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells

1 reference

12 December 2020

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.

1 reference

12 December 2020

The complexity of microenvironment-mediated drug resistance

1 reference

12 December 2020

From concept to clinic: Mathematically informed immunotherapy

1 reference

12 December 2020

Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome

1 reference

12 December 2020

Clonal evolution of glioblastoma under therapy.

1 reference

12 December 2020

Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors

1 reference

12 December 2020

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer

1 reference

12 December 2020

Phase i trials in melanoma: A framework to translate preclinical findings to the clinic

1 reference

12 December 2020

10.1101/CSHPERSPECT.A028332

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC5580509&resulttype=core&format=json

14 May 2020

28289244

1 reference